Nektar Therapeutics
Symbole: 0UNL.L
LSE
1.65
USDPrix du marché aujourd'hui
-1.1419
Ratio P/E
0.0069
Ratio PEG
302.98M
Cap MRK
- 0.00%
Rendement DIV
Nektar Therapeutics (0UNL-L) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 303.6 | 505 | 734 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 283.5 | 438.1 | 719.7 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 2.3 | 6 | 23.9 | ||||||||||||
balance-sheet.row.inventory | 0 | 16.1 | 19.2 | 15.8 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 8.7 | 15.8 | 21.9 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 330.7 | 546 | 795.6 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 36.9 | 85.9 | 177.5 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 76.5 | 76.5 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 76.5 | 76.5 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 25.8 | 0 | 64.8 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 4.6 | 2.2 | 2.7 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 67.3 | 164.6 | 321.6 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 398 | 710.6 | 1117.2 | ||||||||||||
balance-sheet.row.account-payables | 0 | 9.8 | 13 | 9.7 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 19.3 | 18.7 | 17.4 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 112.6 | 126.5 | 148.1 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 22.2 | 36.6 | 58 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 215.8 | 275.8 | 352.5 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 98.5 | 112.8 | 125.7 | ||||||||||||
balance-sheet.row.total-liab | 0 | 267 | 344 | 437.7 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | -3477.2 | -3201.2 | -2833 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0.1 | -6.9 | -4.2 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 3608.1 | 3574.7 | 3516.6 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 131 | 366.6 | 679.5 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 398 | 710.6 | 1117.2 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 0 | 131 | 366.6 | 679.5 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 309.3 | 438.1 | 784.5 | ||||||||||||
balance-sheet.row.total-debt | 0 | 230.4 | 258 | 291.3 | ||||||||||||
balance-sheet.row.net-debt | 0 | 210.2 | 191.1 | 277 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -276.1 | -368.2 | -523.8 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 7.8 | 12.2 | 13 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | -0.1 | 2.7 | -106.6 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | -13 | 57.3 | 94.7 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -19.8 | 0.5 | -23.1 | ||||||||||||
cash-flows.row.account-receivables | 0 | 4.8 | 16.5 | 12.4 | ||||||||||||
cash-flows.row.inventory | 0 | 0.7 | -3.4 | -0.5 | ||||||||||||
cash-flows.row.account-payables | 0 | -2.9 | 3.1 | -11.7 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -22.4 | -15.7 | -23.3 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | 108.6 | -8.5 | 133.1 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.9 | -5.7 | -15 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 1.2 | 13.2 | -217.8 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | -511.7 | -467.9 | -960.7 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 650.9 | 826.2 | 1178.5 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 217.8 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 139.6 | 365.8 | 202.8 | ||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0.8 | 33.2 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 0.8 | 3 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | 1.5 | 36.2 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 6.3 | -0.3 | -0.1 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | -46.7 | 52.5 | -175.1 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 20.2 | 66.8 | 14.3 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 66.8 | 14.3 | 189.3 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | -192.6 | -304 | -412.7 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -0.9 | -5.7 | -15 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | -193.5 | -309.7 | -427.6 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 90.1 | 92.1 | 101.9 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 36.6 | 29.1 | 34.7 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 53.5 | 62.9 | 67.2 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 190.9 | 303.2 | 513.3 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 227.5 | 332.3 | 548 | ||||||||||||
income-statement-row.row.interest-income | 0 | 19 | 22.2 | 44.7 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 25.3 | 28.9 | 47.3 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -138.8 | -124.7 | -77.2 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -138.8 | -124.7 | -77.2 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 25.3 | 28.9 | 47.3 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 7.8 | 12.2 | 13 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | -137.4 | -240.2 | -446.1 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | -276.3 | -365 | -523.3 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | -0.2 | 3.2 | 0.6 | ||||||||||||
income-statement-row.row.net-income | 0 | -276.1 | -368.2 | -523.8 |
Questions fréquemment posées
Quel est le total de Nektar Therapeutics (0UNL.L) de l'actif total?
Nektar Therapeutics (0UNL.L) Le total des actifs est 398033000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est N/A.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.625.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -1.013.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -3.063.
Quel est le revenu total de l'entreprise?
Le revenu total est -1.500.
Qu'est-ce que Nektar Therapeutics (0UNL.L) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -276056000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 230401000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 190903000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 0.000.